-
Investigators have discontinued the FEM-PrEP study of oral emtricitabine and tenofovir disoproxil fumarate (Truvada, Gilead Sciences, Foster City, CA) to prevent HIV infection in women in Africa after interim results indicated the research would be unlikely to prove effectiveness in the study population.
-
The Food and Drug Administration (FDA) and the Federal Trade Commission have issued a joint call to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases (STDs).
-
Results of a new study indicate patients who have tested positive for herpes simplex virus type 2 (HSV-2) but don't have symptoms or genital lesions still experience virus shedding during subclinical episodes.
-
-
-
Much attention has been given to injuries of the cervical spine, but injuries to the thoracolumbar region are actually more common. Because of the anatomy involved, these injuries are often accompanied by multiple serious injuries to other areas of the body and may be overlooked during resuscitation and stabilization.
-
The April 14 issue of the New England Journal of Medicine contains two articles on boceprevir, a new designer molecule that has demonstrated a dramatic improvement in outcomes for patients with genotype 1 hepatitis C.
-
Basically, people now feel nothing is safe to eat. They don't know what choices to make.
-
On Feb. 15, 2011, a 30-month-old U.S.-born child of Somali descent developed a skin rash 14 days after returning from a trip to Kenya and 1 day after visiting a child care center.
-